National Institute of Nursing Research 5R44NR017575-04

Efficacy of a Virtual Reality Neuroscience-based Therapy for Chronic Low Back Pain

This award funds CognifiSense, Inc. to develop and demonstrate the efficacy of a patented virtual reality therapy (VRNT) for chronic low back pain through a pivotal randomized controlled trial, aiming to make the therapy market-ready and provide data for FDA submission.

Description

CognifiSense has developed a unique, patented virtual reality therapy for chronic pain, called Virtual Reality Neuroscience-based Therapy (VRNT), which is specifically designed to create substantial and lasting pain reduction by targeting the centralized drivers of pain chronification and amplification. The goal of this Phase II project is to make the VRNT system market-ready and demonstrate its efficacy in a pivotal randomized controlled trial. Chronic lower back pain (cLBP) is the most common type of chronic pain, affecting 27 million Americans. VRNT uses patented technology that incorporates the latest pain neuroscience and newer, more effective psychological therapies to provide experiential learning and novel skills training to correct maladaptive neural processes. The project aims to port VRNT to a new VR hardware platform, develop sham VR software, and demonstrate VRNT’s clinical efficacy and durability in a sham-controlled randomized controlled trial.

View original record